← Leaderboards
Hasina Hamilton Outtz
Columbia University Health Sciences
$4,286,571
Attributed
$4,661,652
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.3M · FY2007–25$2.5M$1.9M$1.3M$625K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,661,652 · 5
By mechanism
R01$3,660,338 · 3
K01$773,544 · 1
F31$227,770 · 1
Top collaborators
- Wayne William Hancock1 shared
Most similar at Columbia University Health Sciences
Same institution · by research overlap
- Carrie J. Shawber$5,726,596
- Krishnakumar Kizhatil$4,080,371
- Sankar Ghosh$23,629,220
- Audrey Parent$2,717,169
- June Kar-Ming Wu$1,570,888
Others in their field
Top investigators on “Mediating”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Lawrence Corey · Fred Hutchinson Cancer Center$493,822,581
- Barton F Haynes · Duke University$295,802,493
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$286,700,869
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$176,977,598
- Dan H. Barouch · Fred Hutchinson Cancer Center$122,734,499
Research focus
MediatingMouse ModelPathogenesisCellsCause Of DeathBlood VesselsPlayLymphaticPathway InteractionsLymphatic Endothelial CellsLymphatic DrainageLung InjuryAdultImpairmentLungTherapeutic TargetSignal TransductionTissuesInflammationAffectBloodEventLinkLymphatic Vessel
Grant awards (15)
Identifying Novel Roles and the Therapeutic Potential of the Thrombin Receptor Protease Activated Receptor-1 (PAR1) in Lung Lymphatic Function and Acute Respiratory Distress Syndrome$791,503
R01 · FY2025 · HL · contact PI
Lymphatic Dysfunction and Development of Post-Transplant Obliterative Bronchiolitis$750,162
R01 · FY2025 · HL
Lymphatic Dysfunction in the Pathogenesis of COPD$710,964
R01 · FY2025 · HL · contact PI
Lymphatic Dysfunction in the Pathogenesis of COPD$696,745
R01 · FY2024 · HL · contact PI
Lymphatic Dysfunction in the Pathogenesis of COPD$710,964
R01 · FY2023 · HL · contact PI
The Pulmonary Lymphatics in Inflammation and Disease$128,868
K01 · FY2023 · HL · contact PI
The Pulmonary Lymphatics in Inflammation and Disease$128,868
K01 · FY2022 · HL · contact PI
The Pulmonary Lymphatics in Inflammation and Disease$171,936
K01 · FY2021 · HL · contact PI
The Pulmonary Lymphatics in Inflammation and Disease$171,936
K01 · FY2020 · HL · contact PI
The Pulmonary Lymphatics in Inflammation and Disease$171,936
K01 · FY2019 · HL · contact PI
The connection between Notch signaling and VEGFR1 in angiogenesis$43,270
F31 · FY2011 · HL · contact PI
The connection between Notch signaling and VEGFR1 in angiogenesis$46,380
F31 · FY2010 · HL · contact PI
The connection between Notch signaling and VEGFR1 in angiogenesis$46,176
F31 · FY2009 · HL · contact PI
The connection between Notch signaling and VEGFR1 in angiogenesis$45,972
F31 · FY2008 · HL · contact PI
The connection between Notch signaling and VEGFR1 in angiogenesis$45,972
F31 · FY2007 · HL · contact PI